Whilst AD models demonstrated the greatest increase in GFAP expression compared to their respective controls, and CD models the smallest increase, the SMD was not significantly different overall between subgroups (p = 0.02, Fig. 3). This evidence concerns the gene GFAP and Alzheimer disease.